Martin Krug

Novel structure–activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators

Claudius Coburger, Jörg Wollmann, Martin Krug et al. · Bioorganic & Medicinal Chemistry · 2010 · 34 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of 4-anilino α-carbolines as novel Brk inhibitors

Kazem Mahmoud, Martin Krug, Tom Wersig et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Novel Insight in Structure−Activity Relationship and Bioanalysis of P-Glycoprotein Targeting Highly Potent Tetrakishydroxymethyl Substituted 3,9-Diazatetraasteranes

Claudius Coburger, Jörg Wollmann, Christiane Baumert et al. · Journal of Medicinal Chemistry · 2008 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: First structure–activity relationships

Sören Krawczyk, Monika Otto, Alexander Otto et al. · Bioorganic & Medicinal Chemistry · 2011 · 22 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of 4‐Benzylamino‐Substituted α‐Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors

Martin Krug, Kanin Wichapong, German Erlenkamp et al. · ChemMedChem · 2010 · 17 citations

Medicine, Oncology, Pharmacology +12